The Src (Sarcoma) kinase inhibitor PP2 markedly sensitized MLL-rearranged ALL cells otherwise resistant to prednisolone, via downregulation of S100A8 and S100A9, which allowed prednisolone-induced Ca2+ fluxes and trigger apoptosis [66]. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.